Implantation and Injectable Dosage Form New Animal Drugs; Imidocarb Dipropionate
other · Food and Drug Administration · Rule · Published 1997-12-23 · Effective 1997-12-23 · 62 FR 66983
Document
Document number
97-33486
Federal Register citation
62 FR 66983
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1997-12-23
Effective date
1997-12-23
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Schering-Plough Animal Health Corp. The NADA provides for subcutaneous or intramuscular use of imidocarb dipropionate solution for dogs for treatment of babesiosis.